Trial
NCT05689021
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Castration-Resistant Prostate Carcinoma
Intervention
Abiraterone Acetate/Niraparib
Why stopped
Sponsor decided to close due to slow accrual and lack of efficacy
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-22